Gordian Biotechnology

About Gordian Biotechnology

Gordian Biotechnology develops an in vivo drug discovery platform focused on complex age-related diseases. The company uses Target discovery and therapeutic development techniques in animal models to identify therapies that are more likely to succeed in human trials. Its approach centers on Patient Avatars, Mosaic Screening, and the Pythia transcriptome analysis to evaluate how multiple therapies affect dozens of cellular pathways in living organisms. Headquartered in the San Francisco Bay Area, Gordian aims to cure age-related disease and empower people to lead longer, healthier lives.